This mentored research training will be specifically focused on defining efficacy of metformin in the chemoprevention of high risk breast cancer. The post doctoral fellow will be involved in systematically evaluating this agent by conducting (a) population studies to examine the role of metformin in breast cancer morbidity and mortality; (b) in silico evaluation of metformin’s molecular targets; and (c) validation studies of the molecular targets of these agents in in vitro human cellular and in vivo animal models. The fellow will have the opportunity to work with transdisciplinary teams and pioneers in cancer chemoprevention who will provide the necessary mentorship for the next generation of scientists interested in cancer chemoprevention. Candidates should apply online to REQ ID 8195 and complete the molecular & genetic epidemiology postdoctoral training program application. Questions about this opportunity may be directed to Nancy Paradise, Grant Administrator Nancy.Paradise-at-moffitt.org
A PhD degree in epidemiology, public health, medicine or equivalent is required and a strong background in cancer chemoprevention is preferred.